Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy

  • Protocol
  • Intervention

Authors

  • Babasola O Okusanya,

    Corresponding author
    1. Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi-Araba, Experimental and Maternal Medicine Unit, Department of Obstetrics and Gynaecology, Lagos, Nigeria
    • Babasola O Okusanya, Experimental and Maternal Medicine Unit, Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria. babakusanya@yahoo.co.uk.

    Search for more papers by this author
  • Olufemi T Oladapo

    1. Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Maternal and Fetal Health Research Unit, Department of Obstetrics and Gynaecology, Sagamu, Ogun State, Nigeria
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and harms of a policy of prophylactic versus selective blood transfusion in pregnant women with sickle cell disease (SCD).